- The folks at Hoffmann-La Roche are studying Breast Cancer in individuals ages 18 years and older. This clinical trial is slated to start November 2013 and is expected to end circa September 2018.888-662-6728 (U.S. Only) Reference Study ID Number: ML28759 www.roche.com/about_roche/roche_worldwide.htm
|Recruiting||Reference Study ID Number: ML28759 email@example.com||888-662-6728 (U.S. Only)|
This study is officially titled, "CLINICAL PRACTICE SURVEILLANCE OF THE USE OF HERCEPTIN SUBCUTANEOUS IN PATIENTS WITH HER2-POSITIVE EARLY BREAST CANCER (HerSCin)."
Germany - map
For more study details, please visit this link to ClinicalTrials.gov record, which is the source of this webpage.